Aleniglipron Hepatic Impairment Study

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of this study is to evaluate the PK of aleniglipron in participants with Hepatic Impairment to establish scientifically guided dosing recommendations in these special patient populations.
Epistemonikos ID: 40a98ef4becc474fbae299f923453dd3abc70149
First added on: Oct 14, 2026